UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neuromuscular stimulation ameliorates ischemia-induced walking impairment in the rat claudication model

The journal of physiological sciences, 2019-11, Vol.69 (6), p.885-893

2019

Volltextzugriff (PDF)

Discovery and pharmacological effects of a novel GPR142 antagonist

Journal of receptors and signal transduction, 2017-05, Vol.37 (3), p.290-296

2017

Volltextzugriff (PDF)

Novel Oral Derivative UD-017, a Highly Selective CDK7 Inhibitor, Exhibits Anticancer Activity by Inducing Cell-Cycle Arrest and Apoptosis in Human Colorectal Cancer

Hiroshima Journal of Medical Sciences, 2020/03/31, Vol.69(1), pp.23-31

2020

Volltextzugriff (PDF)

Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus

Bioorganic & medicinal chemistry letters, 2012-09, Vol.22 (18), p.5942-5947

2012

Volltextzugriff (PDF)

Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model

Kidney360, 2022-04, Vol.3 (4), p.687-699

2022

Volltextzugriff (PDF)

Efficacy of Keap1-Nrf2 protein-protein interaction inhibitor for progressive phenotype in Alport syndrome mouse model

Japanese Journal of Pediatric Nephrology, 2022, Vol.35 (2), p.161-161

2022

Volltextzugriff (PDF)

Identification of metals from osteoblastic ST-2 cell supernatants as novel OGR1 agonists

Journal of receptors and signal transduction, 2015-09, Vol.35 (5), p.485-492

2015

Volltextzugriff (PDF)

MRGD, a MAS-related G-protein coupled receptor, promotes tumorigenisis and is highly expressed in lung cancer

PloS one, 2012-06, Vol.7 (6), p.e38618

2012

Volltextzugriff (PDF)

Purification and Identification of Activating Enzymes of CS-0777, a Selective Sphingosine 1-Phosphate Receptor 1 Modulator, in Erythrocytes

The Journal of biological chemistry, 2011-07, Vol.286 (28), p.24765-24775

2011

Volltextzugriff (PDF)

Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice

European journal of pharmacology, 2009-12, Vol.624 (1), p.38-44

2009

Volltextzugriff (PDF)

Identification of physiologically active substances as novel ligands for MRGPRD

BioMed research international, 2012-01, Vol.2012, p.816159-9

2012

Volltextzugriff (PDF)

RS-1748, a Novel CC Chemokine Receptor 4 Antagonist, Inhibits Ovalbumin-Induced Airway Inflammation in Guinea Pigs

Biological and Pharmaceutical Bulletin, 2010/06/01, Vol.33(6), pp.1067-1069

2010

Volltextzugriff (PDF)

Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist

Bioorganic & medicinal chemistry letters, 2012-02, Vol.22 (4), p.1788-1792

2012

Volltextzugriff (PDF)

Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes

ACS medicinal chemistry letters, 2013-08, Vol.4 (8), p.790-794

2013

Volltextzugriff (PDF)

MO578: UBE-1099, A Novel Non-Covalent Keap1-NRF2 Inhibitor, Protects Against Renal Ischemia-Reperfusion Injury

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (Supplement_3)

2022

Volltextzugriff (PDF)

UBE-1099, a Novel Non-Covalent Keap1-Nrf2 Inhibitor, Protects Against Renal Ischemia-Reperfusion Injury via Nrf2 Activation: PO2508

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.762-762

2021

Volltextzugriff (PDF)

Nerve Growth Factor-induced Glutamate Release Is via p75 Receptor, Ceramide, and Ca2+ from Ryanodine Receptor in Developing Cerebellar Neurons

The Journal of biological chemistry, 2003-10, Vol.278 (42), p.41259-41269

2003

Volltextzugriff (PDF)

Ascotricins A and B, novel antagonists of sphingosine-1-phosphate receptor 1 from Ascotricha chartarum Berk. SANK 14186

Journal of antibiotics, 2009-07, Vol.62 (7), p.359-364

2009

Volltextzugriff (PDF)

A Novel Sphingosine-1-Phosphate Receptor 1 Antagonist Prevents the Proliferation and Relaxation of Vascular Endothelial Cells by Sphingosine-1-Phosphate

Biological and Pharmaceutical Bulletin, 2010/09/01, Vol.33(9), pp.1500-1505

2010

Volltextzugriff (PDF)

Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors

Bioorganic & medicinal chemistry, 2024-06, Vol.108, p.117775, Article 117775

2024

Volltextzugriff (PDF)

Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P3-sparing S1P1 agonists

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (9), p.3083-3088

2012

Volltextzugriff (PDF)

Synthesis and evaluation of CS-2100, a potent, orally active and S1P3- sparing S1P1 agonist

European journal of medicinal chemistry, 2012-05, Vol.51, p.92-98

2012

Volltextzugriff (PDF)

Novel Keap-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates the Severity of Experimental Alport Syndrome: PO1302

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.418-418

2021

Volltextzugriff (PDF)

Dichloroacetate induces regulatory T‐cell differentiation and suppresses Th17‐cell differentiation by pyruvate dehydrogenase kinase‐independent mechanism

Journal of pharmacy and pharmacology, 2017-01, Vol.69 (1), p.43-51

2017

Volltextzugriff (PDF)

Deorphanization of Dresden G Protein-Coupled Receptor for an Odorant Receptor

Journal of receptors and signal transduction, 2007-01, Vol.27 (4), p.323-334

2007

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(110)
Tagungsberichte
(1)

Sprache

Englisch
(106)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(56)
Humans
(39)
Animals
(31)
Male
(26)
Pharmacology & Pharmacy
(21)
Biological And Medical Sciences
(19)
Female
(16)
Medical Sciences
(16)
Rats
(15)
Pharmacology. Drug Treatments
(14)
Cardiac & Cardiovascular Systems
(13)
Cardiovascular System & Cardiology
(13)
Biochemistry & Molecular Biology
(12)
Mice
(11)
Treatment Outcome
(10)
Transcatheter Aortic Valve Replacement
(9)
Aged, 80 And Over
(8)
Cells, Cultured
(8)
Drug Discovery
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neuromuscular stimulation ameliorates ischemia-induced walking impairment in the rat claudication model

Discovery and pharmacological effects of a novel GPR142 antagonist

Novel Oral Derivative UD-017, a Highly Selective CDK7 Inhibitor, Exhibits Anticancer Activity by Inducing Cell-Cycle Arrest and Apoptosis in Human Colorectal Cancer

Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus

Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model

Efficacy of Keap1-Nrf2 protein-protein interaction inhibitor for progressive phenotype in Alport syndrome mouse model

Identification of metals from osteoblastic ST-2 cell supernatants as novel OGR1 agonists

MRGD, a MAS-related G-protein coupled receptor, promotes tumorigenisis and is highly expressed in lung cancer

Purification and Identification of Activating Enzymes of CS-0777, a Selective Sphingosine 1-Phosphate Receptor 1 Modulator, in Erythrocytes

Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice

Identification of physiologically active substances as novel ligands for MRGPRD

RS-1748, a Novel CC Chemokine Receptor 4 Antagonist, Inhibits Ovalbumin-Induced Airway Inflammation in Guinea Pigs

Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist

Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes

MO578: UBE-1099, A Novel Non-Covalent Keap1-NRF2 Inhibitor, Protects Against Renal Ischemia-Reperfusion Injury

UBE-1099, a Novel Non-Covalent Keap1-Nrf2 Inhibitor, Protects Against Renal Ischemia-Reperfusion Injury via Nrf2 Activation: PO2508

Nerve Growth Factor-induced Glutamate Release Is via p75 Receptor, Ceramide, and Ca2+ from Ryanodine Receptor in Developing Cerebellar Neurons

Ascotricins A and B, novel antagonists of sphingosine-1-phosphate receptor 1 from Ascotricha chartarum Berk. SANK 14186

A Novel Sphingosine-1-Phosphate Receptor 1 Antagonist Prevents the Proliferation and Relaxation of Vascular Endothelial Cells by Sphingosine-1-Phosphate

Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors

Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P3-sparing S1P1 agonists

Synthesis and evaluation of CS-2100, a potent, orally active and S1P3- sparing S1P1 agonist

Novel Keap-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates the Severity of Experimental Alport Syndrome: PO1302

Dichloroacetate induces regulatory T‐cell differentiation and suppresses Th17‐cell differentiation by pyruvate dehydrogenase kinase‐independent mechanism

Deorphanization of Dresden G Protein-Coupled Receptor for an Odorant Receptor

Suchergebnisse filtern